Author:
Regan Meredith M.,Pagani Olivia,Fleming Gini F.,Walley Barbara A.,Price Karen N.,Rabaglio Manuela,Maibach Rudolf,Ruepp Barbara,Coates Alan S.,Goldhirsch Aron,Colleoni Marco,Gelber Richard D.,Francis Prudence A.
Reference22 articles.
1. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 28,896 women;N Engl J Med,1988
2. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women;Lancet,1992
3. Tamoxifen for early breast cancer: an overview of the randomised trials;Lancet,1998
4. Tamoxifen and chemotherapy for lymph node negative, estrogen receptor-positive breast cancer;Fisher;J Natl Cancer Inst,1997
5. Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials;Lancet,2007
Cited by
72 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献